HCA Healthcare (NYSE:HCA) PT Lowered to $420.00 at KeyCorp

HCA Healthcare (NYSE:HCA) had its price target dropped by investment analysts at KeyCorp from $475.00 to $420.00 in a research note issued to investors on Monday, Benzinga reports. The firm presently has an “overweight” rating on the stock. KeyCorp’s price objective indicates a potential upside of 15.73% from the stock’s current price.

Other equities research analysts have also recently issued reports about the stock. Oppenheimer raised their price target on shares of HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Morgan Stanley began coverage on HCA Healthcare in a report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target on the stock. Wells Fargo & Company increased their target price on HCA Healthcare from $365.00 to $395.00 and gave the stock an “equal weight” rating in a report on Tuesday, October 22nd. Barclays upped their price objective on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. Finally, Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Five equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and three have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $374.67.

HCA Healthcare Stock Performance

Shares of HCA opened at $362.90 on Monday. The stock has a market capitalization of $95.05 billion, a P/E ratio of 18.09, a price-to-earnings-growth ratio of 1.52 and a beta of 1.67. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The firm’s fifty day simple moving average is $395.06 and its two-hundred day simple moving average is $352.71. HCA Healthcare has a 12 month low of $222.23 and a 12 month high of $417.14.

Insider Buying and Selling

In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of the company’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the transaction, the senior vice president now owns 9,454 shares in the company, valued at approximately $3,436,623.54. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Kathleen M. Whalen sold 2,987 shares of the company’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the sale, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at $3,436,623.54. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On HCA Healthcare

Several hedge funds and other institutional investors have recently made changes to their positions in HCA. Bangor Savings Bank increased its holdings in HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after acquiring an additional 45 shares in the last quarter. MFA Wealth Advisors LLC bought a new stake in HCA Healthcare in the second quarter worth $27,000. Unique Wealth Strategies LLC bought a new stake in shares of HCA Healthcare during the second quarter worth $28,000. GPS Wealth Strategies Group LLC increased its stake in shares of HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after buying an additional 71 shares during the period. Finally, Benjamin F. Edwards & Company Inc. acquired a new stake in HCA Healthcare in the second quarter worth about $33,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.